The estimated Net Worth of Associates Llc Greenrose is at least $0 dollars as of 3 February 2022. Associates Greenrose owns over 685,289 units of Greenrose Acquisition stock worth over $0 and over the last 5 years Associates sold GNRS stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Associates Greenrose GNRS stock SEC Form 4 insiders trading
Associates has made over 1 trades of the Greenrose Acquisition stock since 2022, according to the Form 4 filled with the SEC. Most recently Associates bought 685,289 units of GNRS stock worth $0 on 3 February 2022.
The largest trade Associates's ever made was buying 685,289 units of Greenrose Acquisition stock on 3 February 2022 worth over $0. On average, Associates trades about 228,430 units every 0 days since 2020. As of 3 February 2022 Associates still owns at least 5,217,789 units of Greenrose Acquisition stock.
You can see the complete history of Associates Greenrose stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Associates Greenrose's mailing address?
Associates's mailing address filed with the SEC is 111, Broadway, Amityville, Suffolk County, New York, 11701, United States.
Insiders trading at Greenrose Acquisition
Over the last 5 years, insiders at Greenrose Acquisition have traded over $0 worth of Greenrose Acquisition stock and bought 736,509 units worth $0 . The most active insiders traders include Associates Llc Greenrose und John Falcon. On average, Greenrose Acquisition executives and independent directors trade stock every 8 days with the average trade being worth of $0. The most recent stock trade was executed by John Falcon on 18 February 2022, trading 51,220 units of GNRS stock currently worth $0.
What does Greenrose Acquisition do?
Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.
What does Greenrose Acquisition's logo look like?
Complete history of Associates Greenrose stock trades at Greenrose Acquisition
Greenrose Acquisition executives and stock owners
Greenrose Acquisition executives and other stock owners filed with the SEC include:
-
William Francis Harley III,
CEO & Director -
Paul Otto Wimer,
Pres & COO -
Daniel Patrick Harley,
Exec. VP of Bus. Devel. & Director -
Anat Kenan,
External Director -
Asher Grinbaum,
External Director -
Yuval Bronstein,
External Director -
David Baruch,
External Director -
Harel Beit-On,
Director -
Noam Robinsohn,
Vice President - Finance -
Erez Balasha,
Chief Executive Officer, Director -
Joseph Singer,
Chairman of the Board -
Bernard Wang,
Chief Financial Officer -
Timothy Bossidy,
Interim Chief Exec. Officer -
Brendan Sheehan,
Exec. VP of Corp. Strategy & Investor Relations and Director -
Nicole Conboy,
Chief Admin. Officer -
Scott J. Cohen,
CFO & Chief Accounting Officer -
John Falcon,
Director -
John Iii Torrance,
Director -
Steven Francis Cummings,
Director -
Thomas J Megale,
Director -
Associates Llc Greenrose,
10% owner -
Jeffrey Stegner,
Former Chief Financial Officer